Gene abnormality found for infant leukaemia:
This article was originally published in Clinica
US scientists have identified a gene abnormality which could lead to an aggressive and deadly form of infant leukaemia. In a study involving 12 infants with acute lymphoblastic leukaemia, the most common form of cancer in children, researchers found that leukaemic cells from all the patients showed a specific abnormality in a gene called Ikaros as well as high levels of defective forms of the Ikaros protein. The study is published in the Proceedings of the National Academy of Sciences (January 19).
You may also be interested in...
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
In a final guidance from the US agency, regulators say most combination product questions are best resolved through traditional pathways and noted that initiating a so-called combination product agreement meeting may be unproductive.